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Original Article
Pancreaticoduodenectomy: A developing country perspective
Khawaja Muhammad Inam Pal, Hassaan Bari, Sana Nasim
Department of Surgery, Aga Khan University Hospital, Karachi.

Abstract
Objective: To review retrospectively, the resultsof Whipple's procedure from 1986 to December 2009 at the Aga
Khan University Hospital.
Methods: Patient's case notes were reviewed to extract information related to demographics, clinical and
laboratory data, operative procedure and post operative period. Surgical mortality was defined as death within
30 days of procedure.
Results: Hundred and twenty one patients underwent a successful pancreaticoduodenectomy during this period.
There were 78 males and 43 females. Most presented with clinical features of obstructive jaundice. Perioperative
evaluation in the majority included an abdominal ultrasound and contrast enhanced CT scan. A preoperative ERCP
was performed in 64 (53%) patients and a stent was placed in 32 (26%). Stent related sepsis was noted in 8 patients
(25 %). Eighty four (69%) patients underwent a standard resection, 31% had a pylorus preserving procedure. The
commonest pathology was adeno-carcinoma located in the pancreatic head or periampullary area. Post operative
morbidity was noted in 54% of patients, the commonest being chest infection (20%) followed by delayed gastric
emptying and pancreatic anastomotic leak. There were 12 perioperative deaths giving a surgical mortality of 10%.
Conclusion: To our understanding this is the largest series of consecutive pancreaticoduodenectomies reported
in Pakistan. Our morbidity and mortality rates compare favourably with international centers of similar yearly case
volume. There is a need to establish regional centers to effectively manage complex disease conditions and
improve the standard of care offered to our patients.
Keywords: Pancreaticoduodenectomy, Whipple’s procedure, adenocarcinoma pancreatic head (JPMA 61:232; 2011).

Introduction
Pancreaticoduodenectomy (PD) is one of the most
complex surgical procedures. Historically it was Walter
Kausch, who in 1909 performed the first successful PD as a
staged procedure. However the regional operative procedure
for periampullary tumours was popularized by Allen
Oldfather Whipple in a paper published in 1935,1 the
procedure now is widely known as "Whipple procedure".
Following Whipple's report, the operation became widely
known but was infrequently performed because of high
operative mortality rates. By the end of Whipple's career, he
had performed 37 such procedures. Operative mortality from
the original report of Whipple to well into the 1970s was in
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excess of 25%.2-4 It was only in 1990s that several major
centers in western countries started reporting significantly
reduced perioperative mortality rates of below 5%, these
were attributable to a combination of improvements in
surgical, anaesthetic/critical care and radiology techniques;
both diagnostic and interventional.5-11 In recent years some
studies12-14 have reported large numbers of consecutive
Whipple procedures without mortality. Carcinoma of the
head of pancreas is the most common indication for
pancreaticoduodenectomy.10,15 With its improved safety
profile PD is now also considered an appropriate treatment
option for selected patients with chronic pancreatitis; this
now constituting the second most common indication for the
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operation.10,15 Despite dramatic reduction in mortality rates
the postoperative morbidity continues to remain high ranging
from 40-50%.16,17
We have reviewed our experience with this procedure
at a single institution over a 24 year period.

Methods
This is a retrospective case note review of all
patients having undergone an elective PD, at the
department of surgery between January 1986 and
December 2009. The records were obtained through the
hospitals health information and management system. A
multivariable form was used to record information. Earlier
data bases for the procedure, maintained in the department
were also used to track missing information.
Demographics, co-morbidities, history of presenting
illness, past history, laboratory and radiological
investigation, intra-operative data including operating time,
estimated blood loss and number of packed cells transfused
during surgery was recorded. Postoperative complications
and mortality were also documented. Operative mortality
was defined as death within 30 days of surgery.

Results
A total of 121 patients underwent PD during the study
period at AKUH. Patients included 78 men and 43 women
(Table-1), with a mean age of 54 ± 9.8 years. The trend line
for annual PD with the number of cases is shown in the
Figure. The most common of all preoperative signs and
symptoms, was jaundice (n=78; 64%), followed by weight
loss (n=70; 58%), pruritus (n=53; 44%) and abdominal pain
(n=39; 32%). Fifty (41%) patients had one or more chronic
comorbid illnesses, which included diabetes mellitus (n=32),
hypertension (n=26), asthma (n=8), cardiovascular disease
(n=6) and CVA (n=1).
Table-1: Patients demographics, presenting
complaints and co-morbids.
Variable
Age, mean ( SD)
Gender
Male
Female
Presenting complaint
Jaundice
Weight loss
Pruritus
Abdominal pain
Co-morbids
DM II
Hypertension
Asthma
Ischaemic heart disease
Stroke

Vol. 61, No. 3, March 2011

Table-2: Histological type and Location of Tumour.
Histological type of Tumour
Adenocarcinoma
Neuroendocrine
GIST
Sarcomatoid carcinoma
Large cell non Hodgkins lymphoma
Benign
Location of Tumour
Pancreatic head
Ampullar & periampullary
Bile duct
Duodenum

N=121

%

109
2
2
1
1
6

90
1.6
1.6
0.8
0.8
5

54*
42
18*
7

45
34
15
6

*Includes location of benign obstruction n=6.

Serum biochemistry demonstrated a raised total
Bilirubin in 76 (63%) patients. Prothrombin time
derangements were noted in 28 (23%) patients. A reduced
serum albumin level was observed in 57 patients (47%).
The majority of patients 71% underwent a
preoperative abdominal CT scan for staging and assessing
resectability. A preoperative ERCP was performed in 64
(52%) patients and a stent was placed in 32 (26%). Stent
related sepsis was noted in 8 (25%) patients.
Magnetic resonance imaging/magnetic resonance
cholangiopancreatography (MRI/MRCP) were used only
infrequently in 4% cases. Conventional ultrasonography
(US) scan was used in 72 (60%) patients.
Adenocarcinoma of the head, periampullary or
ampullary area was the commonest tumour type
accounting for 83 cases. Other tumour types seen are listed
in Table-2. Eighty four (69%) patients underwent classic
PD, whereas pylorus-preserving PD was performed on
thirty-seven (31%) patients. The median blood loss was
1125 ml (range 250 - 3150 ml). Overall operations
required a median transfusion of 2 Units of packed red
blood cells (range 0 - 8 Units).
A total of 124 postoperative complications were

N=121 n (%)
54 ( +/-9.8)
78 (64)
43 (36)
78 (64)
70 (58)
53 (44)
39 (32)
32 (26)
26 (21)
8 (7)
6 (5)
1 (1)

Figure: Yearly pancreaticoduodenectomy rate with trend line.
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recorded in sixty-sixty (55%) patients. Chest infections
(n=26; 21%) were the most common followed by wound
infections (n=24; 20%), delayed gastric emptying (n=20;
16.5%) and pancreatic anastomotic leak 15 (12%).
Postoperative bleeding occurred in 15 patients (12%). Other
less common complications included urinary tract infection
(n=11; 9%), acute renal failure (n=9; 7%), pulmonary
oedema (n=5; 4%), myocardial infarct (n=3; 2.5%) and
thromboembolic disease (n=3; 2.5%).
The occurrence of delayed gastric empting was
significantly (p=0.02) more common in patients who had
pylorus preserving PD (30%) compared to patients who
underwent standard PD (11%). Overall there were twelve
(10%) postoperative deaths within 30 days of surgery.

Discussion
Pancreaticoduodenectomy continues to be one of the
most complex operations and a formidable undertaking for
both; surgeon and patient. The dramatic reduction in perioperative mortality in the past 2 decades is well described in
the literature but most of the reported series come from high
volume referral centers. Recommendations from the same
suggest that this procedure should only be undertaken in
hospitals with well developed multidisciplinary and critical
care facilities.7-11 From the literature one also gets an
impression that the reduction in peri-operative mortality is a
complex mixture of improvements in surgical techniques,
multidisciplinary care and interventional radiology. The fact
that peri-operative morbidities continue to be high also
indirectly supports this assumption. The most obvious
example of this is the dreaded complication of pancreatic
anastomotic leakage, with its potential of proteolytic
enzyme activation, setting off a series of events that lead to
death. With high definition CT scanning and newer
interventional radiology techniques this serious and
previously often fatal complication can now often be
managed conservatively. Another uncommon but
potentially lethal complication is post-operative
haemorrhage; gastro-intestinal or intra-peritoneal. This can
now be successfully managed by angio-embolization or
endoscopy. Three patients in our series needed angioembolic control for life threatening haemorrhage from
stump of gastro-duodenal artery.
The preferred approach to a number of important
perioperative issues has been established over the past
decade and half. Tumour resectability can be well assessed
by present generation high definition (spiral/64slice)
contrast enhanced CT scans and in the vast majority of cases
further tests are not routinely needed. Endo-luminal US may
have a complementary role, but is not well established.
There is now significant evidence that surgical intervention
can safely be undertaken in patients with obstructive
234

jaundice and; biliary decompression is only needed in
patients with very high bilirubin levels or in those with
evidence of biliary sepsis.18-20
The approach to evaluation of suspected neoplastic
obstructive jaundice now dictates a pancreatic protocol
contrast enhanced CT scan as the 1st investigation
following ultrasound and biochemistry. An ERCP should
only be attempted if no lesion can be identified on CT;
surgery is not being considered or palliation is to be offered.
Suspected neoplastic obstructive jaundice continues to be
one of the few conditions where major surgical
interventions can be attempted in the absence of histological
confirmation of suspected diagnosis.
A major as yet unresolved challenge in relation to
this procedure is the nature of the illness, for which it is
most often, employed i.e. adenocarcinoma of the pancreatic
head. This continues to be a lethal illness with a dismal
overall 5 year survival. At presentation up to 80% of
patients are only eligible for palliation. Successful resection
in cases of pancreatic adenocarcinoma does not guarantee
prolonged survival but does improve the chances;21 at
present complete resection followed by adjuvant treatment
with chemotherapy or combination chemo-radiotherapy is
widely considered the best available option, though there
are differing opinions about the benefits of adjuvant
treatment.22,23 The outlook is somewhat better for other
malignancies that may arise in this same anatomical area
like distal bile duct, duodenal or ampullary cancers.
A nihilistic approach to malignant obstructive
jaundice continues to prevail in Pakistan. The main reasons
for this are; a poorly developed primary healthcare system
with its negative impact on referral patterns, and secondly
the scarcity of well developed, tertiary care,
multidisciplinary centers.
Other authors from Pakistan24,25 have published
their experience with this procedure; the numbers involved
have been small. Incidence of morbidities and mortality in
these series has been similar to our experience, though in
both series the time duration under review has not been
specified. We describe what we believe is the largest series
of pancreatoduodenectomies in Pakistan with a critical
look at peri-operative events. Yearly case volume at our
center has slowly but steadily grown over the years and we
are now in the category of a moderate volume center. Our
peri-operative morbidity and mortality rates are
comparable to international centers of similar case
volume.7-9
We identify the need and strongly recommend that
efforts be made to develop regional referral centers to
optimize the care of complex diseases like neoplasia related
obstructive jaundice.
J Pak Med Assoc

hundred and forty-five consecutive pancreaticoduodenectomies without
mortality. Ann Surg 1993; 217: 430-5.
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